in 2Q18. This was mostly due to an increase in revenues from Inpatients, Outpatients and IVF patients. The Company reported Cost of Hospital Operations (including Depreciation and Amortization) of Baht
in 3Q17. This was mostly due to an increase in revenues from Inpatients, Outpatients and IVF patients. The Company reported Cost of Hospital Operations (including Depreciation and Amortization) of Baht
Depreciation and Amortization) of Baht 137.74 million or 34.26% increase year-over-year from Baht 102.59 million in 3Q18. This represents an increase in the cost of doctors, nurses, drugs, medical supplies and
and Outpatients. The Company reported Cost of Hospital Operations including Depreciation and Amortization of Thai Baht 509.33 million in 2019, or 33.28% increase year-over-year from Baht 382.14 million
. Centers operating distinctive income included Pediatrics Center and Emergency Center. The Company reported Cost of Hospital Operations (including Depreciation and Amortization) of Baht 109.59 million for
well as attending Chinese fertility centers which is the main user group of the subsidiary company. The Company reported Cost of Hospital Operations (including Depreciation and Amortization) of THB
from the Covid-19 pandemic and temporary closed stores in each countries. Earnings before Interest, Tax, Depreciation and Amortization (EBITDA) In 1Q 2020, the Company had earnings before interest, tax
from a temporary closure of stores in overseas from the outbreak. Earnings before Interest, Tax, Depreciation and Amortization (EBITDA) In the second quarter of year 2020 the Company and subsidiaries had
Company reported Cost of Hospital Operations including Depreciation and Amortization of Baht 382.14 million in 2018, or 12.72% increase year-over-year from Baht 339.01 million in 2017. This represents an
Restaurant Business 223.2 242.6 (19.5) (8.0) Others 9.1 9.5 (0.4) (3.8) Total 1,801.0 1,837.4 (36.4) (2.0) -2- Earnings before Interest, Tax, Depreciation and Amortization (EBITDA) In the Quarter 2 of 2017